RT Journal Article
SR Electronic
T1 Knowledge mobilisation of rapid evidence reviews to inform health and social care policy and practice in a public health emergency: appraisal of the Wales COVID-19 Evidence Centre processes and impact, 2021-23
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.30.23299238
DO 10.1101/2023.11.30.23299238
A1 Gal, Micaela
A1 Cooper, Alison
A1 Joseph-Williams, Natalie
A1 Doe, Elizabeth
A1 Lewis, Ruth
A1 Law, Rebecca Jane
A1 Anstey, Sally
A1 Davies, Nathan
A1 Walters, Amy
A1 Orford, Robert
A1 Collins, Brendan
A1 Trigg, Lisa
A1 Roberts, Chris
A1 Meredith, Sarah
A1 Macey, Steven
A1 Carson-Stevens, Andrew
A1 Greenwell, Jane
A1 Coomber, Ffion
A1 Edwards, Adrian
YR 2023
UL http://medrxiv.org/content/early/2023/12/01/2023.11.30.23299238.abstract
AB The Wales COVID-19 Evidence Centre (WCEC) was established from 2021-23 to ensure that the latest coronavirus (COVID-19) relevant research evidence was readily available to inform health and social care policy and practice decision-makers. Although decisions need to be evidence-based, ensuring that accessible and relevant research evidence is available to decision-makers is challenging, especially in a rapidly evolving pandemic environment when timeframes for decision-making are days or weeks rather than months or years. We set up knowledge mobilisation processes to bridge the gap between evidence review and informing decisions, making sure that the right information reaches the right people at the right time.Aims and objectives To describe the knowledge mobilisation processes used by the WCEC, evaluate the impact of the WCEC rapid evidence reviews, and share lessons learned.Methods Our knowledge mobilisation methods were flexible and tailored to meet stakeholders needs. They included stakeholder co-production in our rapid evidence review processes, stakeholder-informed and participatory knowledge mobilisation, wider dissemination of outputs and associated activities including public engagement, capacity building and sharing of methodologies. Feedback on processes and evidence of impact was collected via stakeholder engagement and a stakeholder survey.Results Findings indicate that WCEC knowledge mobilisation processes successfully supported co-production and use of rapid evidence review findings by scientific advisors and policy and practice decision-makers during the COVID-19 pandemic. Identified barriers and facilitators are of potential relevance to wider evidence initiatives. Knowledge mobilisation require sustained development to continue building stakeholder links, embed co-production and sustain knowledge mobilisation as we move to support evidence-based policy and practice decision-making beyond the pandemic.Discussion and Conclusion The WCEC knowledge mobilisation processes successfully supported co-production and use of rapid evidence review findings by scientific advisors and policy and practice decision-makers during the COVID-19 pandemic. Identified barriers and facilitators are of potential relevance to wider evidence initiatives. Knowledge mobilisation require sustained development to continue building stakeholder links, embed co-production and sustain knowledge mobilisation as we move to support evidence-based policy and practice decision-making beyond the pandemic.Funding statement The Wales COVID-19 Evidence Centre was funded for this work by Health and Care Research Wales on behalf of Welsh Government.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Wales COVID-19 Evidence Centre was funded for this work by Health and Care Research Wales on behalf of Welsh Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors